Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine

This page shows you your search results in order of relevance. This is page number 14.

Order by Relevance | Date

Total 2010 results found since Jan 2013.

Silent Myocardial Infarction: A Case Report
We present a case of a 59-year-old overweight woman with prediabetes, primary hypertension, and hypercholesterolemia who presented for herpes zoster (HZ) follow-up; she reported having skipped heartbeats and heart rate fluctuations during the review of systems. On further workup, ECG revealed low voltage QRS complexes, flat QRS complexes, flat T waves, and pathological Q waves, suggesting the diagnosis of SMI. Based on the identified risk factors, including high BMI, prediabetes, primary hypertension, hypercholesterolemia, HZ, and newly diagnosed SMI, the patient was advised to continue with lisinopril 20 mg daily, prescri...
Source: Herpes - August 28, 2023 Category: Infectious Diseases Authors: Maria V Kolesova Suzanne Minor Source Type: research

Shingles Becoming More Prominent In All Age Groups
var videoCanvas = new WNVideoWidget("WNVideoCanvas", "wnVideo_8121511");videoCanvas.SetWidth(385);videoCanvas.SetHeight(288);videoCanvas.SetVariable("clipId", "8121511");videoCanvas.SetVariable("transportShareButtons", "cc");videoCanvas.SetReportingKeywords("CBS.BOSTON");videoCanvas.SetAdvertisingZone("CBS.BOSTON/worldnowplayer");videoCanvas.SetVariable("offFaceColor", "afaeae");videoCanvas.SetVariable("overFaceColor", "ffffff");videoCanvas.SetVariable("backgroundColors", "212121,676767,676767,212121");videoCanvas.SetVariable("backgroundAlphas", "0,0,0,0");videoCanvas.SetVariable("backgroundRatios", "0,25,130,255");videoCa...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 1, 2013 Category: Consumer Health News Authors: stevesaleeba Tags: Health Seen On WBZ-TV Syndicated Local Watch Listen Paula Ebben Shingles Source Type: news

A population based study of the epidemiology of Herpes Zoster and its complications
Conclusions: Extrapolating to the entire Israeli population, we estimate over 24,000 new cases of HZ and 1250 new cases of PHN each year. Cost-effectiveness analysis should be performed to determine the threshold age for vaccination against HZ.
Source: Journal of Infection - July 18, 2013 Category: Infectious Diseases Authors: Dahlia Weitzman, Oren Shavit, Michal Stein, Raanan Cohen, Gabriel Chodick, Varda Shalev Tags: Viruses and Viral Diseases Source Type: research

Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries
Conclusions: While HZ vaccination is mostly considered cost-effective, cost-effectiveness of varicella vaccination primarily depends on the in- or exclusion of exogenous boosting in the model. As a consequence, clarification on the role of exogenous boosting is crucial for decision-making regarding varicella vaccination.
Source: BMC Public Health - June 5, 2015 Category: Consumer Health News Authors: Oliver DammBernhard UltschJohannes HornRafael MikolajczykWolfgang GreinerOle Wichmann Source Type: research

Live attenuated herpes zoster vaccine for HIV‐infected adults
ConclusionsIt is recommended that LAHZV be administered to HIV‐infected adults with a CD4 count above 200 cells/μL, the same CD4 threshold used for other live attenuated viral vaccines.
Source: HIV Medicine - August 29, 2015 Category: Infectious Diseases Authors: SD Shafran Tags: Viewpoints on HIV Research Source Type: research

Vaccines for preventing herpes zoster in older adults.
CONCLUSIONS: Herpes zoster vaccine is effective in preventing herpes zoster disease and this protection can last three years. In general, zoster vaccine is well tolerated; it produces few systemic adverse events and injection site adverse events of mild to moderate intensity.There are studies of a new vaccine (with a VZV glycoproteic fraction plus adjuvant), which is currently not yet available for clinical use. PMID: 26937872 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - March 3, 2016 Category: Journals (General) Authors: Gagliardi AM, Andriolo BN, Torloni MR, Soares BG Tags: Cochrane Database Syst Rev Source Type: research

Herpes zoster and the search for an effective vaccine
This article reviews VZV pathogenesis, host responses and current vaccines available to prevent herpes zoster. This article is protected by copyright. All rights reserved.
Source: Clinical and Experimental Immunology - April 30, 2016 Category: Allergy & Immunology Authors: Nicole Arnold, Ilhem Messaoudi Tags: Review Source Type: research

Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.
CONCLUSIONS: Although live vaccinations were safe and sufficiently immunogenic in most studies, some serious reactions and vaccine-related infections were reported in immunosuppressed IMID and SOT patients. Apart from mild vaccine-related infections MMR and VV vaccines were safe when administered less than two years after BMT. IMPLICATIONS OF KEY FINDINGS: Until further data are available, live vaccinations under most immunosuppressive treatments should only be administered after a careful risk benefit assessment of medications and dosages. FUNDING: None. PMID: 28162821 [PubMed - as supplied by publisher]
Source: Vaccine - February 1, 2017 Category: Allergy & Immunology Authors: Croce E, Hatz C, Jonker EF, Visser LG, Jaeger VK, Bühler S Tags: Vaccine Source Type: research

Improving adult immunization equity: Where do the published research literature and existing resources lead?
Abstract Evidence suggests that disparities in adult immunization (AI) rates are growing. Providers need adequate patient resources and information about successful interventions to help them engage in effective practices to reduce AI disparities. The primary purposes of this paper were to review and summarize the evidence base regarding interventions to reduce AI disparities and to scan for relevant resources that could support providers in their AI efforts to specifically target disparities. First, building on a literature review conducted by the U.S. Centers for Disease Control and Prevention, we searched the p...
Source: Vaccine - April 25, 2017 Category: Allergy & Immunology Authors: Prins W, Butcher E, Hall LL, Puckrein G, Rosof B Tags: Vaccine Source Type: research

Cutaneous varicella zoster virus infection following zoster vaccination: report of post-vaccination herpes zoster skin infection and literature review of zoster vaccination efficacy and guidelines. Stiff, Katherine M; Cohen, Philip R
Background Herpes zoster vaccine is currently recommended in the United States for immune competent individuals ≥60 years. The efficacy of the herpes zoster vaccine decreases with age and with time following vaccination. Purpose An elderly man with herpes zoster following vaccination is described. The guidelines for vaccination and issues regarding re-vaccination are reviewed. Methods: Pub Med was used to search the following terms: efficacy, elderly, herpes zoster, herpes zoster incidence, herpes zoster recurrence, and vaccination. The papers and relevant citations were reviewed. The clinical features of a patie...
Source: Dermatology Online Journal - January 1, 2017 Category: Dermatology Source Type: research

Cutaneous varicella zoster virus infection following zoster vaccination: report of post-vaccination herpes zoster skin infection and literature review of zoster vaccination efficacy and guidelines.
ConclusionsHerpes zoster vaccine decreases in efficacy with both age and number of years following vaccination. Therefore, booster shots or revaccination in the older population may be of benefit. PMID: 28633742 [PubMed - in process]
Source: Dermatol Online J - June 15, 2017 Category: Dermatology Authors: Stiff KM, Cohen PR Tags: Dermatol Online J Source Type: research

Herpes zoster prevention: A difficult problem to solve.
Abstract The clinical relevance of herpes zoster (HZ) and its increased incidence in recent years has prompted a search for more effective measures of prevention and therapy. A number of vaccines has been developed. For two of them, the live attenuated HZ vaccine (LAHZV) and the adjuvanted recombinant subunit HZ vaccine (SUHZV), data regarding immunogenicity, efficacy, safety and reactogenicity have been collected. This information allows us to draw some conclusions about what can be expected from their use and what is still required to definitively solve the problem of HZ prevention. The currently licensed vaccin...
Source: Vaccine - August 4, 2017 Category: Allergy & Immunology Authors: Esposito S, Principi N Tags: Vaccine Source Type: research

Epidemiology, treatment and prevention of herpes zoster: A comprehensive review
This study mainly focuses on herpes zoster using articles and reviews from PubMed, Embase, Cochrane library, and a manual search from Google Scholar. We cover the incidence of herpes zoster, gender distribution, seasonal and regional distribution of herpes zoster, incidence of herpes zoster among immunocompromised individuals, incidence of post-herpetic neuralgia following a zoster infection, complications, management, and prevention of herpes zoster and post-herpetic neuralgia.
Source: Indian Journal of Dermatology, Venereology and Leprology - April 13, 2018 Category: Dermatology Authors: Elsam Koshy Lu Mengting Hanasha Kumar Wu Jianbo Source Type: research

Evidence Based Recommendations for Supportive Care in Multiple Myeloma
Conclusion:Along with anti-myeloma chemotherapy therapy, management of complications (anemia, infections, renal insufficiency) and other associated symptoms is necessary to improve the quality of life.DisclosuresNo relevant conflicts of interest to declare.
Source: Blood - November 21, 2018 Category: Hematology Authors: Qureshi, A., Tariq, M. J., Shah, Z., Abu Zar, M., Aslam, S., Rafae, A., Malik, M. N., Kamal, A., Jose, J. A., Selene, I. I., Shafqat, M., Jamil, F., Durer, S., Durer, C., Anwer, F. Tags: 653. Myeloma: Therapy, excluding Transplantation: Poster I Source Type: research